Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells

Journal of Virology

Volumn 77, Issue 10, 2003, Pages 5933-5947

  Zhang, Yuhong ^a   Jamaluddin, Mohammad ^a   Wang, Shaofei ^a   Tian, Bing ^a   Garofalo, Roberto P ^a   Casola, Antonella ^a   Brasier, Allan R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; BETA INTERFERON; COMPLEMENT; CYTOKINE; DNA; INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; PROTEIN IFI 6 16; PROTEIN IFI 9 27; PROTEIN IRF 7B; PROTEIN P56; PROTEIN P78; PROTEIN STAT 1BETA; RIBAVIRIN; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; CELL ASSAY; CHRONIC DISEASE; CONCENTRATION (PARAMETERS); CYTOPATHOGENIC EFFECT; DNA DETERMINATION; DRUG MECHANISM; DRUG POTENCY; EPITHELIUM CELL; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE NUMBER; GENETIC PARAMETERS; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG DISEASE; MUTATION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERFERONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY SYSTEM; RESPONSE ELEMENTS; RIBAVIRIN; UP-REGULATION;

EID: 0038032916     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.10.5933-5947.2003     Document Type: Article

References (67)

1. Adler, K. B., B. M. Fischer, D. T. Wright, L. A. Cohn, and S. Becker. 1994. Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation. Ann. N. Y. Acad. Sci. 725:128-145.
2. Aherne, W. T., T. Bird, S. D. B. Court, P. S. Gardner, and J. McQuillin. 1970. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23:7-18.
3. Atreya, P. L., and S. Kulkarni. 1999. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology 261:227-241.
4. Barnes, P. J., and M. Karin. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071.
5. Becker, S., W. Reed, F. W. Henderson, and T. L. Noah. 1997. RSV infection of human airway epithelial cells causes production of the β-chemokine RANTES. Am. J. Physiol. 272:L512-L520.
6. Bennett, C. R., Jr., and D. Hamre. 1962. Growth and serological characteristics of respiratory syncytial virus. J. Infect. Dis 110:8-16.
7. Bossert, B., and K.-K. Conzelmann. 2002. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76:4287-4293.
8. Brasier, A. R., M. Jamaluddin, A. Casola, W. Duan, Q. Shen, and R. Garofalo. 1998. A promoter recruitment mechanism for TNF-α-induced IL-8 transcription in type II pulmonary epithelial cells: dependence on nuclear abundance of Rel A, NF-κB1, and c-Rel transcription factors. J. Biol. Chem. 273:3551-3561.
9. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques 7:1116-1122.
10. Casola, A., N. Burger, T. Liu, M. Jamaluddin, A. R. Brasier, and R. P. Garofalo. 2001. Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with RSV. J. Biol. Chem. 276:19715-19722.
11. Casola, A., R. Garofalo, M. Jamaluddin, S. Vlahopoulos, and A. R. Brasier. 2000. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J. Immunol. 164:5944-5951.
12. Casola, A., R. P. Garofalo, H. Haeberle, T. Elliott, R. Lin, M. Jamaluddin, and A. R. Brasier. 2001. Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus. J. Virol. 75:6428-6439.
13. Chatterjee-Kishore, M., R. Kishore, D. J. Hicklin, F. M. Marincola, and S. Ferrone. 1998. Different requirements for signal transducer and activator of transcription 1 alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. J. Biol. Chem. 273:16177-16183.
14. Chatterjee-Kishore, M., K. L. Wright, J. P. Ting, and G. R. Stark. 2000. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19:4111-4122.
15. Committee on Infectious Diseases. 1993. Use of ribavirin in the treatment of respiratory syncytial virus in infection. Pediatrics 92:501-504.
16. Crotty, S., C. E. Cameron, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:6895-6900.
17. Di Bisceglie, A. M., J. Thompson, N. Smith-Wilkaitis, E. M. Brunt, and B. R. Bacon. 2001. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Hepatology 33:704-707.
18. Ferenci, P., R. Stauber, P. Steindl-Munda, M. Gschwantler, P. Fickert, C. Datz, C. Muller, F. Hackl, W. Rainer, T. Watkins-Riedel, W. Lin, G. J. Krejs, A. Gangl, and the Austrian Hepatitis Study Group. 2001. Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Hepatology 13:699-705.
19. Ferris, J. A., W. A. Aherne, and W. S. Locke. 1973. Sudden and unexpected deaths to infants: histology and virology. Br. Med. J. 2:439-449.
20. Fiedler, M. A., K. Wernke-Dollries, and J. M. Stark. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:L865-L872.
21. Fiedler, M. A., K. Wernke-Dollries, and J. M. Stark. 1996. Inhibition of viral replication reverses respiratory syncytial virus-induced NF-κB activation and interleukin-8 gene expression in A549 cells. J. Virol. 70:9079-9082.
22. Garenne, M., C. Ronsmans, and H. Campbell. 1992. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat. Q. 45:180-191.
23. Garofalo, R., M. Sabry, M. Jamaluddin, R. K. Yu, A. Casola, P. L. Ogra, and A. R. Brasier. 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the Re1A transcription factor as a mechanism producing airway mucosal inflammation. J. Virol. 70:8773-8781.
24. Garofalo, R., R. C. Welliver, and P. L. Ogra. 1991. Concentrations of LTB4, LTC4, LTD4 and LTE4 in bronchiolitis due to respiratory syncytial virus. Pediatr. Allergy Immunol. 2:30-37.
25. Gershwin, L., S. N. Girid, R. S. Stewart, and J. Chen. 1989. Prostaglandin and thromboxane concentrations in plasma and lung lavage fluids during sequential infection of vaccinated and nonvaccinated calves with bovine respiratory syncytial virus. Am. J. Vet. Res. 50:1254-1262.
26. Gilbert, B. E., and V. Knight. 1986. Biochemistry and clinical applications of ribavirin. Antimicrob. Agents Chemother. 30:201-205.
27. Glezen, W. P., L. H. Taber, and A. L. Frank. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
28. Griese, M., L. I. Gobran, J. S. Douglas, and S. A. Rooney. 1991. Adenosine A2-receptor-mediated phosphatidylcholine secretion in type II pneumocytes. Am. J. Physiol. 260:L52-L60.
29. Grosfeld, H., M. G. Hill, and P. L. Collins. 1995. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J. Virol. 69:5677-5686.
30. Haeberle, H. A., W. A. Kuziel, H.-J. Dieterich, A. Casola, Z. Gatalica, and R. P. Garofalo. 2001. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1α in lung pathology. J. Virol. 75:878-890.
31. Hall, C. B. 2001. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:1917-1928.
32. Hall, C. B., and C. A. McCarthy. 1995. Respiratory syncytial virus, p. 1501. In G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingston, New York, N.Y.
33. Hermoso, M., N. Barrera, B. Morales, S. Perez, and M. Villalon. 2001. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. Eur. J. Physiol. 442:336-345.
34. Horisberger, M. A., G. K. McMaster, H. Zeller, M. G. Wathelet, J. Dellis, and J. Content. 1990. Cloning and sequence analyses of cDNAs for interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: functional study of the corresponding gene promoter. J. Virol. 64:1171-1181.
35. Hruska, J. F., J. M. Bernstein, R. G. Douglas, Jr., and C. B. Hall. 1980. Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob. Agents Chemother. 17:770-775.
36. Jamaluddin, M., A. Casola, R. P. Garofalo, Y. Han, T. Elliott, P. L. Ogra, and A. R. Brasier. 1998. The major component of IκBα proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus infected pulmonary epithelial cells. J. Virol. 72:4849-4857.
37. Jamaluddin, M., R. Garofalo, P. L. Ogra, and A. R. Brasier. 1996. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J. Virol. 70:1554-1563.
38. Jamaluddin, M., T. Meng, J. Sun, I. Boldogh, Y. Han, and A. R. Brasier. 2000. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol. Endocrinol. 14:99-113.
39. Jamaluddin, M., S. Wang, R. Garofalo, T. Elliott, A. Casola, S. Baron, and A. R. Brasier. 2001. IFN-β mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L248-L257.
40. Jiang, Z., M. Kunimoto, and J. A. Patel. 1998. Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus. J. Virol. 72:2496-2499.
41. Lazarowski, E. R., S. J. Mason, L. Clarke, T. K. Harden, and R. C. Boucher. 1992. Adenosine receptors on human airway epithelia and their relationship to chloride secretion. Br. J. Pharmacol. 106:774-782.
42. Long, C. E., J. T. McBride, and C. B. Hall. 1995. Sequelae of respiratory syncytial virus infections: a role for intervention studies. Am. J. Respir. Crit. Care Med. 151:1678-1681.
43. MacDonald, N. E., C. B. Hall, and S. C. Suffin. 1982. Respiratory syncytial viral infection in infants with congenital heart disease. N. Engl. J. Med. 307:397-400.
44. Marie, I., J. E. Durbin, and D. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
45. Martin, L. D., L. G. Rochelle, B. M. Fischer, T. M. Krunkosky, and K. B. Adler. 1997. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur. Respir. J. 10:2139-2146.
46. Min, W., J. S. Pober, and D. R. Johnson. 1996. Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. J. Immunol. 156:3174-3183.
47. Noah, T. L., and S. Becker. 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265:L472-L478.
48. Olzewska-Pazdrak, B., A. Casola, T. Saito, R. Alam, S. E. Crowe, F. Mei, P. L. Ogra, and R. P. Garofalo. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72:4756-4764.
49. Porter, A. C., Y. Chernajovsky, T. C. Dale, C. S. Gilbert, G. R. Startk, and I. M. Kerr. 1988. Interferon response element of the human gene 6-16. EMBO J. 7:85-92.
50. Prince, G. A., A. Mathews, S. J. Curtis, and D. D. Porter. 2000. Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid. J. Infect. Dis. 182:1326-1330.
51. Schall, T. J., K. Bacon, R. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821-1826.
52. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
53. Shay, D. K., R. C. Holman, R. D. Newman, L. L. Liu, J. W. Stout, and L. J. Anderson. 1999. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 282:1440-1446.
54. Shay, D. K., R. C. Holman, G. E. Roosevelt, M. J. Clarke, and L. J. Anderson. 2001. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183:16-22.
55. Sherman, C. T., and A. R. Brasier. 2001. Role of STAT1 and STAT3 in inducible expression of the human angiotensinogen gene by interleukin-6. Mol. Endocrinol. 15:441-457.
56. Stark, G. R., I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
57. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
58. Thomas, L. H., J. S. Friedland, M. Sharland, and S. Becker. 1998. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J. Immunol. 161:1007-1016.
59. Tian, B., Y. Zhang, B. A. Luxon, R. P. Garofalo, A. Casola, M. Sinha, and A. R. Brasier. 2002. Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76:6800-6814.
60. Tibby, S. M., M. Hatherill, S. M. Wright, P. Wilson, A. D. Postle, and I. A. Murdoch. 2000. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 162:1251-1256.
61. Ueba, O. 1978. Respiratory syncytial virus. I. concentration and purification of the infectious virus. Acta Med. Okayama 32:265-272.
62. Vastag, M., J. Skopal, J. Kramer, K. Kolev, Z. Voko, E. Csonka, R. Machovich, and Z. Nagy. 1998. Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4. Immunobiology 199:5-13.
63. Wathelet, M. G., S. Moutschen, P. Defilippi, A. Cravador, M. Collet, G. Huez, and J. Content. 1986. Molecule cloning, full length sequence and preliminary characterization of a 56 kDa protein induced by human interferons. Eur. J. Biochem. 155:11-17.
64. Wathelet, M. G., L. C. Ronco, P. M. Howley, and T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1:507-518.
65. Wyde, P. R. 1998. Respiratory syncytial virus (RSV) disease and prospects for its control. Antivir. Res. 39:63-79.
66. Yu, Q., R. W. Hardy, and G. W. Wertz. 1995. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J. Virol. 69:2412-2419.
67. Zhang, Y., B. A. Luxon, A. Casola, R. P. Garofalo, M. Jamaluddin, and A. R. Brasier. 2001. Expression of RSV-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75:9044-9058.